iVIEW-1201 Phase II IND clinical trial application for the Treatment of Adenoviral Conjunctivitis approved by Indian Regulatory Authority (CDSCO)

Doylestown, Pennsylvania–iVIEW Therapeutics Inc., an innovative specialty pharmaceutical company committed to becoming a leader in topical drug development with specialization focus on ophthalmology, announced that its Phase II clinical trial IND application of iVIEW-1201 for the Treatment of Adenoviral Conjunctivitis has been approved by Indian Regulatory Authority, CDSCO.

Dr. Bo Liang, Chairman & President of iVIEW and Dr. Vijai Kumar, President & CMO of Excel Life Sciences have attended the Subject Expert Committee (SEC) meeting on 06/Jun’19 at Indian FDA and received positive recommendations from SEC. Excel Life Sciences, iVIEW’s partner for conducting studies in India, is expecting the written approval for study from Drug Controller General of India (DCGI) by July. According to Dr. Liang, “we are excited about the fast approval for the study in India and look forward to starting the trial and enrolling patients soon. We believe that iVIEW-1201 will be the first FDQ approved sustained release broad spectrum antiseptic formulation, which will bring significant value to patients as there is no approved treatment for viral conjunctivitis currently. This is an exciting development for iVIEW.” Dr. Kumar commented, “We believe Excel expertise in conducting conjunctivititis trials in India will help the successful trial execution of the phase II trials and speed up the process for market approval.”

About iVIEW Therapeutics Inc.

iVIEW Therapeutics Inc. is a clinical-stage development specialty pharmaceutical company focusing on ophthalmic therapeutics. It’s headquartered at Pennsylvania Biotechnology Center of Bucks County. It is founded by experienced pharmaceutical experts and clinical physician to bring novel ophthalmic drug products to market with speed for unmet medical needs. Please visit: www.iviewtherapeutics.com for more details.

Pennsylvania Biotechnology Center at Bucks County
3805 Old Easton Road
Doylestown PA 18902 USA
Copyright © 2021 iVIEW Therapeutics, Inc. All rights reserved.